Thursday, May 31, 2018 3:19:52 AM
*Sales*
1) Do you have sufficient manufacturing capacity to meet a surge in demand. What is current capacity utilization. If current utilization is high, do they need to add (e.g., spend money) capacity?
2) Is this an order based business? If yes, can they share or quantify order outlook. What’s current order backlog?
3) To the extent that they can share, can you provide rough sales contribution from NHS, Dr. Scholls, B Braun.
4) Any update on US retail penetration. Would near-term FDA approval help? Andy has downplayed this in the past.
*BOD*
1) who is on the board of directors. Who is chairman
*Share structure*
1) can they break down insider ownership.
2) what are their thoughts on current share count vis a vis A/S. Given the pace of conversion of CBs is there a possibility of another increase in A/S by year end?
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM